Palbociclib
CAS 571190-30-2
In Stock
Palbociclib
Cat. No. STUB-API-PALBOCICLIBCAS 571190-30-2In Stock
Technical Data
Cat. No.STUB-API-PALBOCICLIB
CAS571190-30-2
Mol. FormulaC24H29N7O2
Mol. Weight447.543 g/mol
IUPAC6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridinyl)amino]pyrido[2,3-d]pyrimidin-7-one
SMILESCC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C
InChIInChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)
InChI KeyAHJRHEGDXFFMBM-UHFFFAOYSA-N
Purity—
Description
Overview
Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy
Anant Labs manufacture and furnish high quality Palbociclib impurities for global markets. Our Palbociclib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Palbociclib571190-30-2IbrancePD-0332991PD0332991PD 03329916-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-oneG9ZF61LE7GPD 3329916-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one
